Immunotherapy is moving earlier in the treatment pathway

2026 review in International Journal of Molecular Sciences

“Immunotherapy in Head and Neck Cancer—Where Are We …”

This is a more technical article, but it gives a useful picture of where research is heading. Immunotherapy is being investigated not only for recurrent and metastatic disease, but before surgery, alongside radiotherapy/chemoradiotherapy and in locally advanced disease.

The story isn't one new drug. It is that researchers are increasingly learning when and how to use the immune system as part of head and neck cancer treatment.